Skip to content

Suicide Safety Planning Group Treatment: Project Life Force

Suicide Safety Planning Group Treatment - Project Life Force

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02525575
Acronym
PLF
Enrollment
45
Registered
2015-08-17
Start date
2015-10-01
Completion date
2018-03-01
Last updated
2019-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suicide

Brief summary

For suicidal individuals, minimizing future risk and fostering recovery are critical public health concerns, especially among Veterans, as very few effective interventions exist. This proposal tests a novel group psychotherapy treatment that combines emotion regulation skill based, and psychoeducational approaches, with suicide safety planning development and implementation. Project Life Force (PLF), a novel suicide safety planning group intervention has been designed to fill this critical gap and provide a mechanism to develop and enhance suicide safety planning over time. PLF, a 12-session, group psychotherapy intervention, combines Dialectical Behavioral Therapy (DBT) skill based and psychoeducational approaches, to enhance suicide safety planning development and implementation. Veterans revise their plans over several weeks while learning distress tolerance, emotion regulation, and friendship building/interpersonal skills to incorporate into their safety plans and also receive lessons on gun safety and minimizing access to lethal means. Sessions are augmented with 1) training in the use of a suicide safety planning mobile App to promote accessibility and maximize implementation, and 2) didactic information to bolster recovery, including fostering improved connection with the treatment team, and Veteran's family.

Detailed description

Despite the enrichment of VA suicide prevention services and implementation of the national suicide hotline, Veteran suicide completions have risen to 22 per day and suicide attempts numbered over 15,000 in 2012. These data underscore the urgency of developing additional interventions targeting suicidal Veterans. The construction of a Suicide Safety Plan (SSP); a best practice, is mandated throughout the VA system, and a vital component of the VA's coordinated effort at suicide prevention and recovery. The investigators' pilot data on patterns of SSP use in suicidal Veterans over a 30 day time frame demonstrates that only 65% of Veterans used their safety plans, coping strategies listed on the plan were often mismatched or inadequate to the individual's needs, and limited access to the SSP during times of stress negatively impacted its utility. To the investigators' knowledge, there are currently no recommended guidelines or mechanisms for refinement of the SSP in adult populations beyond its initial development. Project Life Force (PLF), a novel suicide safety planning group intervention has been designed to fill this critical gap and provide a mechanism to develop and enhance suicide safety planning over time. PLF, a 12-session, group psychotherapy intervention, combines Dialectical Behavioral Therapy (DBT) skill based and psychoeducational approaches, to enhance suicide safety planning development and implementation. Veterans revise their plans over several weeks while learning distress tolerance, emotion regulation, and friendship building/interpersonal skills to incorporate into their safety plans and also receive lessons on gun safety and minimizing access to lethal means. Sessions are augmented with 1) training in the use of a suicide safety planning mobile App to promote accessibility and maximize implementation, and 2) didactic information to bolster recovery, including fostering improved connection with the treatment team, and Veteran's family. Importantly, the group format mitigates loneliness and fosters increased belongingness, both key risk factors for suicide. Additionally, PLF's weekly format facilitates VA-mandated monitoring for any Veteran placed on the suicide high risk list. Data from this project will test the intervention's feasibility, acceptability and preliminary efficacy and provide pilot data for a larger randomized clinical trial. The project is comprised of two phases. In Phase 1, the investigators will finalize the PLF intervention and accompanying manual and handouts. In Phase 2, the investigators will conduct an open label trial of PLF in 50 suicidal Veterans to evaluate the feasibility and acceptability of the intervention. The investigators will also test whether PLF affects outcomes of suicide ideation, depression, hopelessness, and outpatient compliance by examining clinically meaningful differences in these measures before and after PLF.

Interventions

BEHAVIORALProject Life Force Group Treatment

PLF, a 12-session, group psychotherapy intervention, combines Dialectical Behavioral Therapy (DBT) skill based and psychoeducational approaches, to enhance suicide safety planning development and implementation. Veterans revise their plans over several weeks while learning distress tolerance, emotion regulation, and friendship building/interpersonal skills to incorporate into their safety plans and also receive lessons on gun safety and minimizing access to lethal means. Sessions are augmented with 1) training in the use of a suicide safety planning mobile App to promote accessibility and maximize implementation, and 2) didactic information to bolster recovery, including fostering improved connection with the treatment team, and Veteran's family. Importantly, the group format mitigates loneliness and fosters increased belongingness, both key risk factors for suicide.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Veterans \> 18 * Able to give consent * Recent Completion of a VA suicide safety plan

Exclusion criteria

* IQ\<80 * Does not speak English * Inability to tolerate group therapy format * There is no exclusion based on medical or psychiatric treatment status. * There are no special restrictions with regard to gender, ethnic status or race

Design outcomes

Primary

MeasureTime frameDescription
Beck Scale for Suicide Ideation (BSS)Baseline, 3 Month, 6 MonthBeck Scale for Suicide Ideation is designed to assess severity of suicidal attitudes and plans for suicide. BSS is a 21 item self-report, rated on a scale of 0-2, with a total score range of 0-38 with higher score indicating higher ideation.
Columbia Suicide Rating Scale (C-SSRS)Baseline, 3 Month, 6 MonthThe Columbia Suicide Rating Scale (C-SSRS) will be used to count prospective or treatment emergent suicidal behaviors. The C-SSRS has been used in many treatment trials, and to measure treatment emergent suicidal events during pharmacotherapy. C-SSRS contains a subscale on suicidal ideation which is scored from 1-5; higher numbers indicate increased suicidal thinking. The definition of suicide attempt for the primary outcome will consist of any actual suicide attempt, aborted suicide attempt, or interrupted suicide attempt according to the C-SSRS.
Beck Depression Inventory-IIBaseline, 3 Month, 6 MonthDepression will be measured with the Beck Depression Inventory-II. This scale consisting of 21 items and scored based on a Likert scale, has high internal consistency (Cronbach coefficient = .92). Each question has a set of at least four possible answer choices, ranging in intensity. When the test is scored, a value of 0 to 3 is assigned for each answer and then the total score is used to quantify the participant's degree of depression from 0 = no depression to 63 = maximally severe depression.
Beck Hopelessness ScaleBaseline, 3 Month, 6 MonthHopelessness is assessed with the Beck Hopelessness Scale, a 20-item self-report measure with true-false items that assess hopelessness and the extent of positive and negative beliefs about the future. Summed scores range from 0 to 20. Scores provide a measure of the severity of self-reported hopelessness: 0-3 minimal, 4-8 mild, 9-14 moderate, and 15-20 severe. Adequate reliability and concurrent validity data exist for this measure, which has been shown to be predictive of eventual suicide in psychiatric inpatients.

Countries

United States

Participant flow

Recruitment details

During the life of the project, 45 subjects signed consent. Of those that consented 37 completed baseline assessments.

Participants by arm

ArmCount
Project Life Force Group Treatment
A manualized, weekly 90-minute group treatment lasting 3 months coinciding with the time frame for enhanced monitoring of Veterans identified as high-risk. This is an open-label pilot study. All participants received the intervention.
37
Total37

Baseline characteristics

CharacteristicProject Life Force Group Treatment
Age, Categorical
Age
<=18 years
0 Participants
Age, Categorical
Age
>=65 years
2 Participants
Age, Categorical
Age
Between 18 and 65 years
35 Participants
Age, Continuous46.43 years
STANDARD_DEVIATION 11.83
Ethnicity (NIH/OMB)
Ethnicity
Hispanic or Latino
20 Participants
Ethnicity (NIH/OMB)
Ethnicity
Not Hispanic or Latino
17 Participants
Ethnicity (NIH/OMB)
Ethnicity
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
Race
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Race
Asian
1 Participants
Race (NIH/OMB)
Race
Black or African American
14 Participants
Race (NIH/OMB)
Race
More than one race
1 Participants
Race (NIH/OMB)
Race
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Race
Unknown or Not Reported
9 Participants
Race (NIH/OMB)
Race
White
12 Participants
Region of Enrollment
United States
37 Participants
Sex: Female, Male
Sex
Female
8 Participants
Sex: Female, Male
Sex
Male
29 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 37
other
Total, other adverse events
8 / 37
serious
Total, serious adverse events
10 / 37

Outcome results

Primary

Beck Depression Inventory-II

Depression will be measured with the Beck Depression Inventory-II. This scale consisting of 21 items and scored based on a Likert scale, has high internal consistency (Cronbach coefficient = .92). Each question has a set of at least four possible answer choices, ranging in intensity. When the test is scored, a value of 0 to 3 is assigned for each answer and then the total score is used to quantify the participant's degree of depression from 0 = no depression to 63 = maximally severe depression.

Time frame: Baseline, 3 Month, 6 Month

ArmMeasureGroupValue (MEAN)Dispersion
Project Life Force Group TreatmentBeck Depression Inventory-IIBaseline33.51 score on a scaleStandard Deviation 10.64
Project Life Force Group TreatmentBeck Depression Inventory-II3 Month23 score on a scaleStandard Deviation 13.16
Project Life Force Group TreatmentBeck Depression Inventory-II6 Month18.13 score on a scaleStandard Deviation 14.59
Primary

Beck Hopelessness Scale

Hopelessness is assessed with the Beck Hopelessness Scale, a 20-item self-report measure with true-false items that assess hopelessness and the extent of positive and negative beliefs about the future. Summed scores range from 0 to 20. Scores provide a measure of the severity of self-reported hopelessness: 0-3 minimal, 4-8 mild, 9-14 moderate, and 15-20 severe. Adequate reliability and concurrent validity data exist for this measure, which has been shown to be predictive of eventual suicide in psychiatric inpatients.

Time frame: Baseline, 3 Month, 6 Month

ArmMeasureGroupValue (MEAN)Dispersion
Project Life Force Group TreatmentBeck Hopelessness ScaleBaseline11.69 score on a scaleStandard Deviation 5.83
Project Life Force Group TreatmentBeck Hopelessness Scale3 Month9.52 score on a scaleStandard Deviation 5.26
Project Life Force Group TreatmentBeck Hopelessness Scale6 Month7.25 score on a scaleStandard Deviation 7.07
Primary

Beck Scale for Suicide Ideation (BSS)

Beck Scale for Suicide Ideation is designed to assess severity of suicidal attitudes and plans for suicide. BSS is a 21 item self-report, rated on a scale of 0-2, with a total score range of 0-38 with higher score indicating higher ideation.

Time frame: Baseline, 3 Month, 6 Month

ArmMeasureGroupValue (MEAN)Dispersion
Project Life Force Group TreatmentBeck Scale for Suicide Ideation (BSS)Baseline17.68 score on a scaleStandard Deviation 9.2
Project Life Force Group TreatmentBeck Scale for Suicide Ideation (BSS)3 Month11.6 score on a scaleStandard Deviation 11.04
Project Life Force Group TreatmentBeck Scale for Suicide Ideation (BSS)6 Month10.71 score on a scaleStandard Deviation 11.01
Primary

Columbia Suicide Rating Scale (C-SSRS)

The Columbia Suicide Rating Scale (C-SSRS) will be used to count prospective or treatment emergent suicidal behaviors. The C-SSRS has been used in many treatment trials, and to measure treatment emergent suicidal events during pharmacotherapy. C-SSRS contains a subscale on suicidal ideation which is scored from 1-5; higher numbers indicate increased suicidal thinking. The definition of suicide attempt for the primary outcome will consist of any actual suicide attempt, aborted suicide attempt, or interrupted suicide attempt according to the C-SSRS.

Time frame: Baseline, 3 Month, 6 Month

ArmMeasureGroupValue (MEAN)Dispersion
Project Life Force Group TreatmentColumbia Suicide Rating Scale (C-SSRS)Baseline3.93 score on a scaleStandard Deviation 1.16
Project Life Force Group TreatmentColumbia Suicide Rating Scale (C-SSRS)3 Month2.25 score on a scaleStandard Deviation 1.25
Project Life Force Group TreatmentColumbia Suicide Rating Scale (C-SSRS)6 Month2.13 score on a scaleStandard Deviation 1.25

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026